Crewe Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.9K | Hold |
120
| – | – | ﹤0.01% | 447 |
|
2025
Q1 | $13.6K | Hold |
120
| – | – | ﹤0.01% | 395 |
|
2024
Q4 | $12.7K | Sell |
120
-34
| -22% | -$3.59K | ﹤0.01% | 406 |
|
2024
Q3 | $16.6K | Sell |
154
-80
| -34% | -$8.64K | ﹤0.01% | 426 |
|
2024
Q2 | $25.4K | Hold |
234
| – | – | ﹤0.01% | 509 |
|
2024
Q1 | $30.9K | Buy |
+234
| New | +$30.9K | ﹤0.01% | 432 |
|
2023
Q4 | – | Sell |
-200
| Closed | -$22.4K | – | 714 |
|
2023
Q3 | $22.4K | Hold |
200
| – | – | ﹤0.01% | 192 |
|
2023
Q2 | $29.1K | Hold |
200
| – | – | ﹤0.01% | 322 |
|
2023
Q1 | $25.8K | Sell |
200
-24
| -11% | -$3.1K | ﹤0.01% | 383 |
|
2022
Q4 | $28.6K | Sell |
224
-86
| -28% | -$11K | ﹤0.01% | 369 |
|
2022
Q3 | $32K | Buy |
310
+35
| +13% | +$3.61K | 0.01% | 383 |
|
2022
Q2 | $29K | Buy |
275
+75
| +38% | +$7.91K | 0.01% | 362 |
|
2022
Q1 | $26K | Buy |
200
+76
| +61% | +$9.88K | 0.01% | 282 |
|
2021
Q4 | $15K | Hold |
124
| – | – | ﹤0.01% | 295 |
|
2021
Q3 | $18K | Sell |
124
-80
| -39% | -$11.6K | ﹤0.01% | 222 |
|
2021
Q2 | $32K | Hold |
204
| – | – | 0.01% | 184 |
|
2021
Q1 | $32K | Hold |
204
| – | – | 0.01% | 183 |
|
2020
Q4 | $31K | Hold |
204
| – | – | 0.01% | 172 |
|
2020
Q3 | $27K | Buy |
204
+80
| +65% | +$10.6K | 0.01% | 168 |
|
2020
Q2 | $14K | Hold |
124
| – | – | 0.01% | 152 |
|
2020
Q1 | $12K | Sell |
124
-23
| -16% | -$2.23K | 0.01% | 140 |
|
2019
Q4 | $21K | Buy |
147
+23
| +19% | +$3.29K | 0.01% | 152 |
|
2019
Q3 | $16K | Hold |
124
| – | – | 0.01% | 169 |
|
2019
Q2 | $14K | Hold |
124
| – | – | ﹤0.01% | 200 |
|
2019
Q1 | $15K | Hold |
124
| – | – | ﹤0.01% | 170 |
|
2018
Q4 | $12K | Hold |
124
| – | – | ﹤0.01% | 178 |
|
2018
Q3 | $16K | Sell |
124
-123
| -50% | -$15.9K | 0.01% | 182 |
|
2018
Q2 | $26K | Buy |
247
+123
| +99% | +$12.9K | 0.02% | 161 |
|
2018
Q1 | $13K | Hold |
124
| – | – | 0.01% | 211 |
|
2017
Q4 | $14K | Buy |
+124
| New | +$14K | 0.01% | 207 |
|